More on INVA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $21.28 |
|
|||
| Open | $21.20 | ||||
| 52 Wk High | $14.15 | ||||
| 52 Wk Low | $7.56 | ||||
| Day High | $21.36 | ||||
| Day Low | $20.89 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 441,923 | ||||
- Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
- Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
- Form 4 Innoviva, Inc. For: Aug 20 Filed by: Zhen Marianne
- Form 4 Innoviva, Inc. For: Aug 20 Filed by: Basso Stephen
- Form 4 Innoviva, Inc. For: Aug 20 Filed by: Raifeld Pavel
- Inova Technology (INVA) Reiterated at Overweight by Cantor Fitzgerald Post Webinar With CEO, CFO
- Innoviva unit's three antibiotics named Prix Galien USA finalists
- Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
- H.C. Wainwright Reiterates Buy Rating on Inova Technology, Inc. (INVA)
- Innoviva (INVA) Misses Q2 EPS by 157c
Entities mentioned with INVA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- PDUFA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
